BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 26704922)

  • 1. The Effect of High-Mobility Group Box 1 in Rat Steatotic and Nonsteatotic Liver Transplantation From Donors After Brain Death.
    Cornide-Petronio ME; Negrete-Sánchez E; Mendes-Braz M; Casillas-Ramírez A; Bujaldon E; Meroño N; Martínez-Carreres L; Gracia-Sancho J; Rodés J; Jiménez-Castro MB; Peralta C
    Am J Transplant; 2016 Apr; 16(4):1148-59. PubMed ID: 26704922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EGF-GH Axis in Rat Steatotic and Non-steatotic Liver Transplantation From Brain-dead Donors.
    Álvarez-Mercado AI; Negrete-Sánchez E; Gulfo J; Ávalos de León CG; Casillas-Ramírez A; Cornide-Petronio ME; Bujaldon E; Rotondo F; Gracia-Sancho J; Jiménez-Castro MB; Peralta C
    Transplantation; 2019 Jul; 103(7):1349-1359. PubMed ID: 31241554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of brain death in rat steatotic and non-steatotic liver transplantation with previous ischemic preconditioning.
    Jiménez-Castro MB; Meroño N; Mendes-Braz M; Gracia-Sancho J; Martínez-Carreres L; Cornide-Petronio ME; Casillas-Ramirez A; Rodés J; Peralta C
    J Hepatol; 2015 Jan; 62(1):83-91. PubMed ID: 25111175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NO-IL-6/10-IL-1β axis: a new pathway in steatotic and non-steatotic liver grafts from brain-dead donor rats.
    Casillas-Ramírez A; Micó-Carnero M; Sánchez-González A; Maroto-Serrat C; Trostchansky A; Peralta C
    Front Immunol; 2023; 14():1178909. PubMed ID: 37593740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Dietary Nutritional Treatment on Hepatic and Intestinal Damage in Transplantation with Steatotic and Non-Steatotic Liver Grafts from Brain Dead Donors.
    Micó-Carnero M; Casillas-Ramírez A; Caballeria-Casals A; Rojano-Alfonso C; Sánchez-González A; Peralta C
    Nutrients; 2021 Jul; 13(8):. PubMed ID: 34444713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is ischemic preconditioning a useful strategy in steatotic liver transplantation?
    Fernández L; Carrasco-Chaumel E; Serafín A; Xaus C; Grande L; Rimola A; Roselló-Catafau J; Peralta C
    Am J Transplant; 2004 Jun; 4(6):888-99. PubMed ID: 15147422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclic adenosine 3',5'-monophosphate in rat steatotic liver transplantation.
    Jimenez-Castro MB; Casillas-Ramirez A; Massip-Salcedo M; Elias-Miro M; Serafin A; Rimola A; Rodes J; Peralta C
    Liver Transpl; 2011 Sep; 17(9):1099-110. PubMed ID: 21671350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of cortisol in rat steatotic and non-steatotic liver transplantation from brain-dead donors.
    Jiménez-Castro MB; Negrete-Sánchez E; Casillas-Ramírez A; Gulfo J; Álvarez-Mercado AI; Cornide-Petronio ME; Gracia-Sancho J; Rodés J; Peralta C
    Clin Sci (Lond); 2017 Apr; 131(8):733-746. PubMed ID: 28246131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-Talk Between Sirtuin 1 and High-Mobility Box 1 in Steatotic Liver Graft Preservation.
    Zaouali MA; Panisello A; Lopez A; Folch E; Castro-Benítez C; Adam R; Roselló-Catafau J
    Transplant Proc; 2017 May; 49(4):765-769. PubMed ID: 28457391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FGF15 improves outcomes after brain dead donor liver transplantation with steatotic and non-steatotic grafts in rats.
    Gulfo J; Rotondo F; Ávalos de León CG; Cornide-Petronio ME; Fuster C; Gracia-Sancho J; Jiménez-Castro MB; Peralta C
    J Hepatol; 2020 Nov; 73(5):1131-1143. PubMed ID: 32422221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ischemic preconditioning induces autophagy and limits necrosis in human recipients of fatty liver grafts, decreasing the incidence of rejection episodes.
    Degli Esposti D; Sebagh M; Pham P; Reffas M; Poüs C; Brenner C; Azoulay D; Lemoine A
    Cell Death Dis; 2011 Jan; 2(1):e111. PubMed ID: 21368883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved rat steatotic and nonsteatotic liver preservation by the addition of epidermal growth factor and insulin-like growth factor-I to University of Wisconsin solution.
    Zaouali MA; Padrissa-Altés S; Ben Mosbah I; Alfany-Fernandez I; Massip-Salcedo M; Casillas-Ramirez A; Bintanel-Morcillo M; Boillot O; Serafin A; Rimola A; Rodés J; Roselló-Catafau J; Peralta C
    Liver Transpl; 2010 Sep; 16(9):1098-111. PubMed ID: 20818748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic targets in liver transplantation: angiotensin II in nonsteatotic grafts and angiotensin-(1-7) in steatotic grafts.
    Alfany-Fernandez I; Casillas-Ramirez A; Bintanel-Morcillo M; Brosnihan KB; Ferrario CM; Serafin A; Rimola A; Rodés J; Roselló-Catafau J; Peralta C
    Am J Transplant; 2009 Mar; 9(3):439-51. PubMed ID: 19191767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammatory genes in rat livers from cardiac- and brain death donors.
    Saat TC; Susa D; Kok NF; van den Engel S; Roest HP; van der Laan LJ; IJzermans JN; de Bruin RW
    J Surg Res; 2015 Sep; 198(1):217-27. PubMed ID: 26003011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenosine monophosphate-activated protein kinase and nitric oxide in rat steatotic liver transplantation.
    Carrasco-Chaumel E; Roselló-Catafau J; Bartrons R; Franco-Gou R; Xaus C; Casillas A; Gelpí E; Rodés J; Peralta C
    J Hepatol; 2005 Dec; 43(6):997-1006. PubMed ID: 16085333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are angiotensin II receptor antagonists useful strategies in steatotic and nonsteatotic livers in conditions of partial hepatectomy under ischemia-reperfusion?
    Ramalho FS; Alfany-Fernandez I; Casillas-Ramirez A; Massip-Salcedo M; Serafín A; Rimola A; Arroyo V; Rodés J; Roselló-Catafau J; Peralta C
    J Pharmacol Exp Ther; 2009 Apr; 329(1):130-40. PubMed ID: 19116369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deficiency of neutrophil high-mobility group box-1 in liver transplant recipients exacerbates early allograft injury in mice.
    Song Z; Han H; Ge X; Das S; Desert R; Athavale D; Chen W; Komakula SSB; Lantvit D; Nieto N
    Hepatology; 2023 Sep; 78(3):771-786. PubMed ID: 37016762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retinol binding protein 4 and retinol in steatotic and nonsteatotic rat livers in the setting of partial hepatectomy under ischemia/reperfusion.
    Elias-Miró M; Massip-Salcedo M; Raila J; Schweigert F; Mendes-Braz M; Ramalho F; Jiménez-Castro MB; Casillas-Ramírez A; Bermudo R; Rimola A; Rodes J; Peralta C
    Liver Transpl; 2012 Oct; 18(10):1198-208. PubMed ID: 22685091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Addition of carvedilol to University Wisconsin solution improves rat steatotic and nonsteatotic liver preservation.
    Ben Mosbah I; Roselló-Catafau J; Alfany-Fernandez I; Rimola A; Parellada PP; Mitjavila MT; Lojek A; Ben Abdennebi H; Boillot O; Rodés J; Peralta C
    Liver Transpl; 2010 Feb; 16(2):163-71. PubMed ID: 20104484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melatonin protects steatotic and nonsteatotic liver grafts against cold ischemia and reperfusion injury.
    Zaoualí MA; Reiter RJ; Padrissa-Altés S; Boncompagni E; García JJ; Ben Abnennebi H; Freitas I; García-Gil FA; Rosello-Catafau J
    J Pineal Res; 2011 Mar; 50(2):213-21. PubMed ID: 21108657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.